Neuropathix
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3805 Old Easton Rd, Doylestown, Pennsylv...Phone Number
(215) 695-6559Website
www.neuropathix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Neuropathix
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from the company's proprietary socially responsible pain management therapeutics to treat patients with a variety of unmet medical needs.Explore more
Neuropathix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neuropathix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Neuropathix
Website visits: Recent activity has been detected on your website
Check if Neuropathix has recently received funding, and reach out quickly before it becomes old news!
Click to see if Neuropathix had a recent Job posting/layoffs
Product Launch: Get notified when Neuropathix launches new products
Funding: Get notified immidiatlly once Neuropathix has new funding data
Earning: See what the market has to say on Neuropathix recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Neuropathix is spiking on competitors!
Neuropathix, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Neuropathix
Find 2 more new buyers
Compare Similar Companies to Neuropathix
Compare insights from companies similar to Neuropathix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neuropathix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neuropathix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuropathix.
Neuropathix Tech Stack
A closer look at the technologies used by Neuropathix
See more technologies
Neuropathix News & Media
Neuropathix, Inc. Announces Publication of Validated Preclinical Studies on KLS-13019 in the British Journal of Pharmacology
DOYLESTOWN, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today the publication of research findings from a study that was performed by scientists at Neuropathix and the Lewis Katz School of Medicine at Temple University. The findings, published in the British Journal of Pharmacology, show the ability of Neuropathix’s patented compound KLS-13019 to prevent and reverseNeuropathix, Inc. CEO Recaps 2020 Advances and Potential Ahead
DOYLESTOWN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today that it has issued a letter to its shareholders providing commentary on the Company’s recent initiatives and corporate updates.Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the publication of its global WIPO/PCT Patent WO 2020/ 264324 – “Use of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids (“PUFAs”) as Neuroprotective Agents” (the “PUFA Patent”).Neuropathix, Inc. Appoints World-Renowned Pain Management Clinician Dr. Daniel Richman to the Company’s Scientific Advisory Board
DOYLESTOWN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today that it has appointed pain management expert Dr. Daniel Richman to the Company’s Board of Advisors.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuropathix
Sign Up For FreeTo access detailed company insights
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from the company's proprietary socially responsible pain management therapeutics to treat patients with a variety of unmet medical needs.... Read More
